No products in the cart.
Roll over image to zoom in
RENODAPT 750MG TABLET
₹672.00₹1,610.71 (-58%)
Renodapt 750 mg Tablet can be described as an anti-inflammatory with an active ingredient, Mycophenolate mofetil. It falls under the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop the rejection of organs in patients who have had one of their organs (such as heart, kidney and liver transplants). It is usually prescribed as a part of a combination treatment, including other immunosuppressive medicines.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It should not be used during pregnancy unless there are no other alternatives and the possible advantages outweigh the risks. Women who are born are strongly advised to use effective contraception when taking this tablet to avoid pregnancies. Due to the reduced effectiveness and possible infection, live vaccines shouldn’t be administered when taking Renodapt 750 mg Tablet. People taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. It is a way to ensure that the drug has been completely removed from the body before donating blood.
It is recommended not to use this medication when allergic to the drug or other components. Inform your physician about heart or liver problems before beginning treatment. Since this medication weakens the body’s immune system, it increases the risk of developing skin cancer. People should minimize their exposure to sun and UV (UV) ultraviolet (UV) light. Contact your physician immediately when you experience skin bruising and fever or if you experience unresolved dizziness, fatigue, discoloration of the skin or eyes, vision impairment, reduced urine output, or seizures following this medication. Renodapt 750 mg Tablet is an immunosuppressive drug. It could impact the development of the infant’s immune system and should not be used during breastfeeding. In some instances, alternatives that have an enhanced safety profile for breastfeeding can be thought of as.